These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38568449)

  • 21. Synthesis and Preclinical Evaluation of [
    Liang H; Chen Z; Mo C; Tang G
    J Labelled Comp Radiopharm; 2024 Aug; 67(10):334-340. PubMed ID: 39041590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, preclinical evaluation, and a pilot clinical imaging study of [
    Xie Q; Liu T; Ding J; Zhou N; Meng X; Zhu H; Li N; Yu J; Yang Z
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3129-3140. PubMed ID: 33630145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical evaluation and pilot clinical study of [
    Ge L; Fu Z; Wei Y; Shi D; Geng Y; Fan H; Zhang R; Zhang Y; Li S; Wang S; Shi H; Song G; Pan J; Cheng K; Wang L
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4025-4036. PubMed ID: 35715613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Al
    Pauwels E; Cleeren F; Tshibangu T; Koole M; Serdons K; Dekervel J; Van Cutsem E; Verslype C; Van Laere K; Bormans G; Deroose CM
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2398-2399. PubMed ID: 31367905
    [No Abstract]   [Full Text] [Related]  

  • 25. [
    Wei Y; Cheng K; Fu Z; Zheng J; Mu Z; Zhao C; Liu X; Wang S; Yu J; Yuan S
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1671-1681. PubMed ID: 34870727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct comparison of [
    Ahenkorah S; Cawthorne C; Murce E; Deroose CM; Cardinaels T; Seimbille Y; Bormans G; Ooms M; Cleeren F
    Nucl Med Biol; 2023; 118-119():108338. PubMed ID: 37018875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of occult neoplasia in a patient with dermatomyositis using [
    Ye Z; Yao Y; Yin J; Kou Y; Zhao M; Cheng Z
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(2):119-120. PubMed ID: 38159845
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis and preclinical evaluation of a novel probe [
    Mo C; Sun P; Liang H; Chen Z; Wang M; Fu L; Huang S; Tang G
    Bioorg Chem; 2024 Jun; 147():107352. PubMed ID: 38640719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Efficient Method for Labeling Single Domain Antibody Fragments with
    Zhou Z; Devoogdt N; Zalutsky MR; Vaidyanathan G
    Bioconjug Chem; 2018 Dec; 29(12):4090-4103. PubMed ID: 30384599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimized labeling of NOTA-conjugated octreotide with F-18.
    Laverman P; D'Souza CA; Eek A; McBride WJ; Sharkey RM; Oyen WJ; Goldenberg DM; Boerman OC
    Tumour Biol; 2012 Apr; 33(2):427-34. PubMed ID: 22009690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and preclinical evaluation of a novel molecular probe [
    Sun P; Mo C; Bai L; Wang M; Chen Z; Zhang M; Han Y; Liang H; Tang G
    Bioorg Chem; 2024 Apr; 145():107193. PubMed ID: 38442611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.
    De Luca S; Fonti R; Camera L; Salvatore B; Faggiano A; Ciarmiello A; Segreto S; Colao A; Salvatore M; Del Vecchio S
    Ann Nucl Med; 2016 Apr; 30(3):234-41. PubMed ID: 26753628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visualization of Activated Fibroblasts in Heart Failure with Preserved Ejection Fraction with [
    Sun F; Wang C; Feng H; Yu F; Zhang X; Zhang P; Du X
    Mol Pharm; 2023 May; 20(5):2634-2641. PubMed ID: 37043243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of [
    Wang M; Zhang H; Wang H; Feng H; Deng H; Wu Z; Lu H; Li Z
    Mol Pharm; 2018 Aug; 15(8):3093-3100. PubMed ID: 29889537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early, non-invasive detection of radiation-induced lung injury using PET/CT by targeting CXCR4.
    Pei J; Cheng K; Liu T; Gao M; Wang S; Xu S; Guo Y; Ma L; Li W; Wang B; Yu J; Liu J
    Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1109-1120. PubMed ID: 38030744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective head-to-head comparison of
    Jiang Y; Liu Q; Wang G; Sui H; Wang R; Wang J; Zhu Z
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4218-4227. PubMed ID: 35657429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automated GMP compliant production of [
    Tshibangu T; Cawthorne C; Serdons K; Pauwels E; Gsell W; Bormans G; Deroose CM; Cleeren F
    EJNMMI Radiopharm Chem; 2020 Jan; 5(1):4. PubMed ID: 31997090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts.
    Persson M; Liu H; Madsen J; Cheng Z; Kjaer A
    Nucl Med Biol; 2013 Jul; 40(5):618-24. PubMed ID: 23602763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated radiosynthesis and preclinical evaluation of Al[
    Huang S; Wu H; Li B; Fu L; Sun P; Wang M; Hu K
    Nucl Med Biol; 2020; 82-83():64-71. PubMed ID: 32088580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2.
    Gao H; Lang L; Guo N; Cao F; Quan Q; Hu S; Kiesewetter DO; Niu G; Chen X
    Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):683-92. PubMed ID: 22274731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.